Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000257925 is annotated as a long non-coding RNA (lncRNA) gene located on chromosome 12 (positions 47,237,734-47,279,021, reverse strand) and is described as a novel transcript antisense to FAM113B. As an antisense transcript, it is transcribed from the DNA strand opposite to the FAM113B gene, but its biological function, expression profile, or relevance to disease is not established in major reference sources. Antisense lncRNAs in general can play regulatory roles in gene expression by various mechanisms (e.g., modulating mRNA stability, transcriptional interference), but there is no data indicating that this specific transcript has been studied, linked to disease, or designated as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to FAM113B (ENSG00000257925).